Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 9INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2Breast 2

Conditions

Neoplasms 1905Breast Neoplasms 1426Carcinoma, Non-Small-Cell Lung 1179Prostatic Neoplasms 740Colorectal Neoplasms 686Neoplasm Metastasis 624Multiple Myeloma 548Melanoma 529Ovarian Neoplasms 456Lung Neoplasms 447Lymphoma, Non-Hodgkin 385Recurrence 374Lymphoma 374Leukemia, Myeloid, Acute 370Pancreatic Neoplasms 358Carcinoma, Renal Cell 339Carcinoma, Hepatocellular 286Stomach Neoplasms 281Leukemia, Lymphocytic, Chronic, B-Cell 268Lymphoma, Follicular 254Head and Neck Neoplasms 246Glioblastoma 220Leukemia 215Small Cell Lung Carcinoma 183Lymphoma, Large B-Cell, Diffuse 183Squamous Cell Carcinoma of Head and Neck 181Urinary Bladder Neoplasms 175Carcinoma 175Uterine Cervical Neoplasms 174Advanced Solid Tumors 161

Interventions

Testosterone Propionate 1Phenylephrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × INDUSTRY × Sexual Dysfunctions, Psychological × Clear all
NCT00612742 2021-10-29

BLOOM

BioSante Pharmaceuticals

Phase 3 Completed
3,656 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT03592121 2020-03-12

Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

Applied Biology, Inc.

Phase EARLY_PHASE1 Completed
3 enrolled 6 charts
BreastOther

Breast Neoplasms, Sexual Dysfunction, Physiological, Sexual Dysfunctions, Psychological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡